| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA1265 | Adapalene (CD 271) | Potency | 1.189 | uM | ALA2114843 | inconclusive | nM | Homo sapiens | |||
| 2. | ALA1265 | Adapalene (CD 271) | AC50 | 39.811 | uM | ALA3562119 | inactive | nM | ||||
| 3. | ALA1265 | Adapalene (CD 271) | Activity | 0 | ALA3423811 | Not Active | Homo sapiens | |||||
| 4. | ALA1265 | Adapalene (CD 271) | %max | = | 260 | % | ALA3423810 | % | Homo sapiens | |||
| 5. | ALA1265 | Adapalene (CD 271) | EC50 | = | 1.3 | uM | ALA3423809 | 5.89 | nM | Homo sapiens | ||
| 6. | ALA1265 | Adapalene (CD 271) | Activity | = | 172 | % | ALA3423808 | % | Homo sapiens | |||
| 7. | ALA1265 | Adapalene (CD 271) | inhibition | = | -0.03 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 8. | ALA1265 | Adapalene (CD 271) | inhibition | = | -0.17 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 9. | ALA1265 | Adapalene (CD 271) | inhibition | = | -0.15 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 10. | ALA1265 | Adapalene (CD 271) | Inhibition | = | 32.949 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 11. | ALA1265 | Adapalene (CD 271) | Inhibition | = | 17.94 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 12. | ALA1265 | Adapalene (CD 271) | Inhibition | = | 33.24 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 13. | ALA1265 | Adapalene (CD 271) | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
| 14. | ALA1265 | Adapalene (CD 271) | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
| 15. | ALA1265 | Adapalene (CD 271) | inhibition | = | -0.15 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 16. | ALA1265 | Adapalene (CD 271) | inhibition | = | -0.03 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 17. | ALA1265 | Adapalene (CD 271) | inhibition | = | -0.17 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
| 18. | ALA1265 | Adapalene (CD 271) | inhibition | = | 0.17 | % | ALA4808150 | % | Homo sapiens | |||
| 19. | ALA1265 | Adapalene (CD 271) | inhibition | = | -51.71 | % | ALA4808149 | % | Homo sapiens | |||
| 20. | ALA1265 | Adapalene (CD 271) | Growth Rate | = | 0 | ALA4725213 | Homo sapiens |
The page will load shortly, Thanks for your patience!